Paolo Bossi, MD, University of Brescia, Brescia, Italy, discusses treatment deintensification and intensification for patients with HPV-positive vs HPV-negative head and neck cancer, as well as the importance of artificial intelligence in diagnosis and treatment and the role of immunotherapy in this field. This interview took place at the 2023 European Congress on Head and Neck Oncology (ECHNO) in Lisbon, Portugal.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть